GAO Memory Supplement Review Recalls FDA's Regulatory Challenges

摘要

GAO recommends better cooperation between FDA and FTC and more public outreach are key to preventing consumers from believing noncompliant cognitive benefit claims for supplements. FDA's capability to keep dietary supplements with noncompliant formulations or claims off the market did not improve in the eight years between Government Accountability Office reports on the agency's oversight of the industry.